Sanofi To Buy Flexion Therapeutics, Inc. For +$1 Billion In Cash
March 23, 2017 at 19:04 PM EDT
Sanofi is in talks to buy Flexion Therapeutics, Inc. a Boston-area biotech with its lead product now awaiting FDA approval, for more than $1 billion in cash, according to a source close to the deal.
